Investigate Europe

Investigating a changing Europe

  • Investigations
  • Magazine
  • Newsletter
  • Donate
  • EN
    ItalianoFrançaisEnglishDeutsch

Select Language

  • Italiano
  • Français
  • English
  • Deutsch

About us

  • The Team
  • Donors
  • Media Partners

Contact us

  • Contact us
  • Leak to us
  • Opportunities

Recent Investigations

  • Untaxed
  • Perenco Files
  • Fuelling war

Our Podcast

  • Untaxed – come le politiche fiscali dei governi hanno alimentato l’emergenza abitativa
  • Untaxed - how governments lure capital into real estate and feed the housing crisis
  • Perenco files: Les secrets toxiques d’un géant du pétrole

Magazine: Our latest articles

  • French contractor, Italian-owned trains, EU policies: Greek crash was also a European failure
  • Congo: European oil companies' secret interests with ruling family
  • The Luxembourg businessman who got Europe's corporate registries shut down - and his secret offshore interests
  • Twitter
  • Facebook
  • Instagram
Investigate Europe 2023
  • Imprint
  • Privacy

Investigate Europe

  • Investigation: Vaccines
  • Donate

vaccine

13 May 2020 Vaccines

Reinhilde Veugelers, Belgian economist: “Governments must fully finance the development of the vaccine”

By Ingeborg Eliassen

Reinhilde Veugelers: Senior Fellow at Bruegel, Professor at Faculty of Economics and Business at the Catholic University of Leuven. Co-author of the April 2020 report Racing against Covid-19: A vaccine strategy for Europe. Why did you make this report? In discussions about Covid-19, it has … Read more "Reinhilde Veugelers, Belgian economist: “Governments must fully finance the development of the vaccine”"

13 May 2020 Vaccines

European Alliance for Responsible R&D and Affordable Medicines: “If the public is an investor, it should act like one and demand something in return”

By Ingeborg Eliassen

The European Alliance for Responsible R&D and Affordable Medicines sprang out of a  price conflict between Germany, France and the US drug producer Gilead on price of Sovaldi, a treatment for hepatitis C, in 2014. Rich Western countries such as France and Italy couldn’t afford the drug … Read more "European Alliance for Responsible R&D and Affordable Medicines: “If the public is an investor, it should act like one and demand something in return”"

  • Contact
  • Donate
  • Leak to us
  • Twitter
  • Facebook
  • Instagram
Investigate Europe 2023
  • Imprint
  • Privacy

Stay up to date

Subscribe to our newsletter and be the first to read our next investigation.
Signup now

Direct to your inbox

Subscribe to our newsletter and be the first to read our next investigation.